Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2014
12/25/2014US20140378471 Substituted oxindole derivatives and their use as vasopressin receptor ligands
12/25/2014US20140378464 Pyrimidinedione compounds
12/25/2014US20140378458 N-Thio-anthranilamid compounds and their use as pesticides
12/25/2014US20140378457 Inhibitors of c-fms kinase
12/25/2014US20140378455 New use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
12/25/2014US20140378453 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
12/25/2014US20140378444 Targeted nitroxide agents
12/25/2014US20140378442 Phthalazinone derivatives
12/25/2014US20140378430 Heterocyclic Compounds and Methods of Their Use
12/25/2014US20140378429 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using Them
12/25/2014US20140378428 2,5-Disubstituted-Pyridyl Nicotinic Ligands, and Methods of Use Thereof
12/25/2014US20140378421 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
12/25/2014US20140377247 Benzamides and related inhibitors of factor xa
12/25/2014US20140377223 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
12/24/2014CN104247072A 有机电致发光元件 Organic electroluminescent element
12/24/2014CN104245688A 活化ampk的吲哚和吲唑类化合物 Activation of indole and indazole compounds ampk of
12/24/2014CN104245686A 新有机电致发光化合物和使用该化合物的有机电致发光器件 The new organic electroluminescent compounds and the use of the compounds are organic electroluminescent devices
12/24/2014CN104245675A 作为MetAP-2抑制剂的环酰胺 As MetAP-2 inhibitor cyclic amide
12/24/2014CN104245671A 含氮杂环化合物或其盐 Nitrogen-containing heterocyclic compounds or salts thereof
12/24/2014CN104245666A 取代的邻氨基苯甲酸衍生物的制备方法 The method for preparing substituted anthranilic acid derivative
12/24/2014CN104230946A 抑制丙肝病毒的化合物、药物组合物及其应用 Compounds inhibit hepatitis C virus, pharmaceutical compositions and use
12/24/2014CN104230911A 作为syk或jak蛋白激酶抑制剂的2,6-二氨基-嘧啶-5-基甲酰胺类化合物 Jak as syk inhibitors of protein kinases or 2,6-diamino - pyrimidin-5-yl carboxamides
12/24/2014CN104230896A 苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途 Benzimidazole-2-piperazine heterocyclic compounds, pharmaceutical compositions and their preparation and use
12/24/2014CN104230892A 一组提高激酶活性的化合物及其应用 Kinase activity of a group of compounds improving its Application
12/24/2014CN104230891A 一种托匹司他的制备方法 One kind of care nepicastat preparation
12/24/2014CN104230890A 吡啶-2-胺衍生物及其制法和药物组合物与用途 Pyridin-2-amine derivatives their preparation and pharmaceutical compositions and uses
12/24/2014CN104230889A 环丙沙星衍生物及其制备方法与用途 Ciprofloxacin and its preparation method and use derivatives
12/24/2014CN104230888A 一种苯并咪唑化合物的制备方法 Method for preparing benzimidazole compound
12/24/2014CN104230887A 达比加群酯新中间体及其制备方法 Dabigatran new intermediates and preparation methods
12/24/2014CN104230886A 阿昔替尼新晶型 Abciximab imatinib new polymorph
12/24/2014CN104230885A 伊马替尼的制备方法 Imatinib preparation
12/24/2014CN104230884A 伊马替尼中间体及其制备方法 Imatinib intermediates and its preparation method
12/24/2014CN104230861A 胺类化合物和包括该胺类化合物的有机发光装置 Amines and organic light emitting device includes the amine compound
12/24/2014CN104230827A 1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮作为parp抑制剂及其应用 1- (aryl-ylmethyl) quinazoline -2,4 (1h, 3h) - dione as a parp inhibitors and their Applications
12/24/2014CN104230826A 2-氟代喹唑啉环类化合物及其制备方法和药用用途 2- fluoro quinazoline ring compounds and preparation method and medicinal uses
12/24/2014CN104230766A 甲酰胺衍生物、中间体、制备方法、药物组合物和应用 Carboxamide derivatives, intermediates, preparation methods, pharmaceutical compositions and applications
12/24/2014CN103347872B 双环化合物 Bicyclic compounds
12/24/2014CN103304538B 右旋甲氟喹的合成 Synthesis of D-mefloquine
12/24/2014CN103153963B 环丙烷化合物 Cyclopropane compound
12/24/2014CN103012379B 苯丙氨酸类衍生物及制备方法和用途 Phenylalanine derivatives and the preparation and use
12/24/2014CN102933573B 包含酰胺衍生物或其可药用盐的药物组合物 Pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof
12/24/2014CN102887888B 一种基于萘酰亚胺荧光增白剂的返黄抑制剂及其制备方法和应用 Based naphthalimide fluorescent brighteners yellowing inhibitors and their preparation method and application
12/24/2014CN102863428B 作为丙型肝炎病毒抑制剂的螺环化合物 Hepatitis C virus inhibitors as spiro compounds
12/24/2014CN102850328B 吡啶类化合物、其制备方法、包含该化合物的药物组合物及其用途 Pyridine compounds, methods for their preparation, pharmaceutical compositions comprising the compounds and their use
12/24/2014CN102753527B 用作crf受体拮抗剂的环己基酰胺衍生物 Receptor antagonists used as crf cyclohexyl amide derivative
12/24/2014CN102675282B 取代的喹啉化合物及其使用方法和用途 Substituted quinoline compounds and methods of use and uses
12/24/2014CN102548557B 用于降低β-淀粉状蛋白生成的化合物 For reducing the compound β- amyloid generated
12/24/2014CN102464612B 含哌嗪氨基甲酸酯的二卤丙烯醚类化合物与应用 Piperazine-containing urethane dihalopropene ether compound and Applications
12/24/2014CN102341387B 四唑基肟衍生物及其盐、以及植物病害防除剂 Tetrazolyl oxime derivatives and salts thereof, as well as plant disease control agent
12/24/2014CN102292323B 芳基甲基苯并喹唑啉酮m1受体正向变构调节剂 Aryl methyl ketone benzquinazolino m1 receptor positive allosteric modulators
12/24/2014CN101875653B 1,2,3-3h吡啶杂环化合物的制备及用途 1,2,3-3h preparation and use of pyridine heterocyclic compounds
12/23/2014US8916710 Method for producing tetrazole-substituted anthranilic acid diamide derivatives by reacting pyrazolic acids with anthranilic acid esters
12/23/2014US8916708 Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract
12/23/2014US8916704 Dihydroquinone derivatives of piperidine and piperazine
12/23/2014US8916702 Compounds for the treatment of hepatitis C
12/23/2014US8916605 Compounds and methods for treating cancer and viral infections
12/23/2014US8916601 Aza-aryl 1H-pyrazol-1-YL benzene sulfonamides
12/23/2014US8916600 Phenyl and benzodioxinyl substituted indazoles derivatives
12/23/2014US8916599 1H-benz imidazole-5-carboxamides as anti-inflammatory agents
12/23/2014US8916593 Alkoxy-substituted 2-aminopyridines as ALK inhibitors
12/23/2014US8916591 Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
12/23/2014US8916590 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
12/23/2014US8916585 Nitrogen-containing heteroaryl compounds and methods of use thereof
12/23/2014US8916579 5-fluoropyrimidinone derivatives
12/23/2014US8916576 Pharmacokinetically improved compounds
12/23/2014US8916575 Quinazoline derivatives for the treatment of viral infections and further diseases
12/23/2014US8916574 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors
12/23/2014US8916573 Quinazoline-2,4-dione derivatives
12/23/2014US8916572 Bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinase
12/23/2014US8916569 Compounds and methods for inhibiting phosphate transport
12/23/2014US8916566 Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
12/23/2014US8916561 Substituted quinoxaline compounds for the inhibition of PASK
12/23/2014US8916560 Heterocyclic compounds for the inhibition of PASK
12/23/2014US8916557 Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines
12/23/2014US8916555 3,5-diaminopyrazole kinase inhibitors
12/23/2014US8916554 Amino-derivatives as novel inhibitors of histone deacetylase
12/23/2014US8916553 Sulfonamide compounds useful as CYP17 inhibitors
12/23/2014US8916550 Compounds for modulating TRPV3 function
12/23/2014US8916548 5-alkynyl-pyrimidines
12/23/2014US8916275 Light emitting device material and light emitting device
12/23/2014US8916183 Pesticidal compositions and processes related thereto
12/18/2014US20140371461 Process for producing n-(hetero)arylazoles
12/18/2014US20140371273 Polymorphs of perampanel
12/18/2014US20140371269 Phenyl methanesulfonamide derivatives useful as mgat-2 inhibitors
12/18/2014US20140371268 Biphenylcarboxamides as rock kinase inhibitors
12/18/2014US20140371266 Mono Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
12/18/2014US20140371247 Selective and Reversible Inhibitors of Ubiquitin Specific Protease 7
12/18/2014US20140371246 Phosphatidylinositol 3-kinase inhibitors
12/18/2014US20140371239 Menin-mll inhibitors and methods of use thereof
12/18/2014US20140371238 Compounds and methods for the treatment of cystic fibrosis
12/18/2014US20140371225 Pyridazinone compounds and methods for the treatment of cystic fibrosis
12/18/2014US20140371222 Triazole compounds that modulate hsp90 activity
12/18/2014US20140371221 Quinoline compound composing 1,2,4-triazine-dione and use thereof
12/18/2014US20140371220 Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors
12/18/2014US20140371213 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
12/18/2014US20140371209 S1P Modulating Agents
12/18/2014US20140371207 Chemokine receptor antagonists and methods of use thereof
12/18/2014US20140371205 Substituted pyrimidines for the treatment of diseases such as cancer
12/18/2014US20140371202 Indazole compounds as kinase inhibitors and method of treating cancer with same
12/18/2014US20140371201 Bicyclic sulfonamide compounds as sodium channel inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 1080